| 2018 | Physiologically-based pharmacokinetic predictions of intestinal BCRP-mediated drug interactions of rosuvastatin in Koreans
| Korean J Physiol Pharmacol |
| 2018 | Comparison of biosimilar filgrastim with a reference product: pharmacokinetics, pharmacodynamics, and safety profiles in healthy volunteers
| DRUG DESIGN DEVELOPMENT AND THERAPY |
| 2018 | Coagulant Effect and Tolerability of Yeast-Produced Recombinant Batroxobin in Healthy Adult Subjects | CLINICAL DRUG INVESTIGATION |
| 2017 | Use of a Target-Mediated Drug Disposition Model to Predict the Human Pharmacokinetics and Target Occupancy of GC1118, an Anti-epidermal Growth Factor Receptor Antibody
| BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY |
| 2017 | Pharmacokinetic interactions between glimepiride and rosuvastatin in healthy Korean subjects: does the SLCO1B1 or CYP2C9 genetic polymorphism affect these drug interactions? Observations and introspection of the bioanalysis
| DRUG DESIGN DEVELOPMENT AND THERAPY |
| 2017 | Decreased potency of fimasartan in liver cirrhosis was quantified using mixed-effects analysis
| Translational and Clinical Pharmacology |
| 2017 | Pharmacokinetic drug interaction between atorvastatin and ezetimibe in healthy Korean volunteers
| Transl Clin Pharmacol |
| 2017 | Population pharmacokinetics of remifentanil in critically ill patients receiving extracorporeal membrane oxygenation
| SCIENTIFIC REPORTS |
| 2017 | Effects of clarithromycin on the pharmacokinetics of evogliptin in healthy volunteers | JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS |
| 2017 | Comparison of Pharmacokinetics and Safety of a Fixed-dose Combination of Rosuvastatin and Ezetimibe Versus Separate Tablets in Healthy Subjects | CLINICAL THERAPEUTICS |
| 2016 | Comparison of oral absorption models for pregabalin: usefulness of transit compartment model
| Drug Des Devel Ther |
| 2016 | Effects of JOINS® on the pharmacokinetic profiles of aceclofenac in healthy Korean volunteers: an open-label, multiple-dose, one sequence, two-period study
| Translational and Clinical Pharmacology |
| 2016 | Pharmacokinetics, pharmacodynamics and safety of CKD-519, a CETP inhibitor, in healthy subjects
| DRUG DESIGN DEVELOPMENT AND THERAPY |
| 2015 | Pharmacokinetic Interaction Between Amlodipine and Lobeglitazone, a Novel Peroxisome Proliferator–activated Receptor-γ Agonist, in Healthy Subjects | CLINICAL THERAPEUTICS |
| 2014 | First-in-human study with new recombinant agalsidase beta (ISU303) in healthy subjects | JOURNAL OF CLINICAL PHARMACOLOGY |
| 2014 | Verapamil decreases the glucose-lowering effect of metformin in healthy volunteers
| BRITISH JOURNAL OF CLINICAL PHARMACOLOGY |
| 2014 | Effect of Ketoconazole on Lobeglitazone Pharmacokinetics in Korean Volunteers | CLINICAL THERAPEUTICS |
| 2013 | Influence of Hepatic Dysfunction on the Pharmacokinetics and Safety of Fimasartan | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY |
| 2013 | Impact of ABCC2, ABCG2 and SLCO1B1 polymorphisms on the pharmacokinetics of pitavastatin in humans
| DRUG METABOLISM AND PHARMACOKINETICS |
| 2013 | Functional characterization of MATE2-K genetic variants and their effects on metformin pharmacokinetics | PHARMACOGENETICS AND GENOMICS |
